COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Peter Rummens, Daniël Schuermans, Hélène Simonis, Olivier Vandenplas, Florence Schleich
Abstract
<b>In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19.</b>https://bit.ly/3ndZmyD
Topics & Concepts
MedicineAsthmaCohortCoronavirus disease 2019 (COVID-19)PediatricsDiseaseCohort studyEosinophilicInternal medicineInfectious disease (medical specialty)PathologyAsthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchIL-33, ST2, and ILC Pathways